In a public health breakthrough, U.S. obesity rates have decreased for the first time in more than a decade, with new weight ...

Results of the study indicate that Black women in the U.S., ages 66-75, saw the largest decrease in obesity between 2022-2023 ...

KOCHI: Obesity has grown into a global epidemic, affecting nearly every corner of the world. According to 2022 data from the ...

Altimmune is redefining success in both obesity and MASH to position Pemvidutide in blue ocean categories. Read why I rate ...

The secret agent in the decrease might be semaglutide, a GLP-1 receptor agonist that fuels popular weight loss drugs like ...

Obesity prevalence in the US decreased in 2023, with significant drops in the South, highlighting the impact of GLP-1RA ...

On its own, obesity can cause acute ailments, including breathlessness and back pain. Worse, it often leads to other chronic ...

A new study reveals that modulating endocannabinoids in the brain can reduce food intake and boost physical activity, ...

Endocannabinoids in the brain play a key role in food intake and energy use. Modulating the action of these molecules could help fight obesity, say researchers.

A new study published in the JAMA Health Forum found that obesity rates dropped from 46% in 2022 to 45.6% in 2023. The study ...

If coverage is structured properly, it could greatly help our country's chronic disease and obesity epidemics. But Donald Trump's Food and Drug Administration (FDA) will also need to ensure the drugs ...

With a little more certainty coming to the market, the R&D environment in 2025 will be about pipeline prioritization and ...